Pharmacotherapy in cancer patients with HIV/AIDS

J. H. Beumer, R. Venkataramanan, Michelle Rudek-Renaut

Research output: Contribution to journalArticle

Abstract

Antiretroviral therapy (ART) has significantly reduced morbidity and increased life expectancy of individuals infected with human immunodeficiency virus (HIV). Consequently, non-acquired immunodeficiency syndrome (AIDS)-defining malignancies are increasing in frequency, which necessitates the concurrent use of antineoplastics and ART. Although drug interactions are a major concern when combining these agents, there is currently limited guidance on dose adjustments required to maintain safe and efficacious drug exposure.

Original languageEnglish (US)
Pages (from-to)370-372
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume95
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
Drug Therapy
Life Expectancy
Drug Interactions
Antineoplastic Agents
Neoplasms
Morbidity
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Pharmacotherapy in cancer patients with HIV/AIDS. / Beumer, J. H.; Venkataramanan, R.; Rudek-Renaut, Michelle.

In: Clinical Pharmacology and Therapeutics, Vol. 95, No. 4, 2014, p. 370-372.

Research output: Contribution to journalArticle

Beumer, J. H. ; Venkataramanan, R. ; Rudek-Renaut, Michelle. / Pharmacotherapy in cancer patients with HIV/AIDS. In: Clinical Pharmacology and Therapeutics. 2014 ; Vol. 95, No. 4. pp. 370-372.
@article{b17fa9f2139b435594c48aa9afbdede6,
title = "Pharmacotherapy in cancer patients with HIV/AIDS",
abstract = "Antiretroviral therapy (ART) has significantly reduced morbidity and increased life expectancy of individuals infected with human immunodeficiency virus (HIV). Consequently, non-acquired immunodeficiency syndrome (AIDS)-defining malignancies are increasing in frequency, which necessitates the concurrent use of antineoplastics and ART. Although drug interactions are a major concern when combining these agents, there is currently limited guidance on dose adjustments required to maintain safe and efficacious drug exposure.",
author = "Beumer, {J. H.} and R. Venkataramanan and Michelle Rudek-Renaut",
year = "2014",
doi = "10.1038/clpt.2014.10",
language = "English (US)",
volume = "95",
pages = "370--372",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Pharmacotherapy in cancer patients with HIV/AIDS

AU - Beumer, J. H.

AU - Venkataramanan, R.

AU - Rudek-Renaut, Michelle

PY - 2014

Y1 - 2014

N2 - Antiretroviral therapy (ART) has significantly reduced morbidity and increased life expectancy of individuals infected with human immunodeficiency virus (HIV). Consequently, non-acquired immunodeficiency syndrome (AIDS)-defining malignancies are increasing in frequency, which necessitates the concurrent use of antineoplastics and ART. Although drug interactions are a major concern when combining these agents, there is currently limited guidance on dose adjustments required to maintain safe and efficacious drug exposure.

AB - Antiretroviral therapy (ART) has significantly reduced morbidity and increased life expectancy of individuals infected with human immunodeficiency virus (HIV). Consequently, non-acquired immunodeficiency syndrome (AIDS)-defining malignancies are increasing in frequency, which necessitates the concurrent use of antineoplastics and ART. Although drug interactions are a major concern when combining these agents, there is currently limited guidance on dose adjustments required to maintain safe and efficacious drug exposure.

UR - http://www.scopus.com/inward/record.url?scp=84897024689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897024689&partnerID=8YFLogxK

U2 - 10.1038/clpt.2014.10

DO - 10.1038/clpt.2014.10

M3 - Article

C2 - 24440966

AN - SCOPUS:84897024689

VL - 95

SP - 370

EP - 372

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -